Study suggests $35 monthly insulin cap has increased patient accessnews2026-04-07T18:52:01+00:00April 7th, 2026|Endpoints News|
White House adds AbbVie’s Humira to TrumpRx alongside cheaper biosimilarsnews2026-04-07T18:10:11+00:00April 7th, 2026|Endpoints News|
Terns sold to Merck for 13% lower than pharma’s initial offer because of clinical datanews2026-04-07T15:30:06+00:00April 7th, 2026|Endpoints News|
Gilead continues dealmaking streak with $3.15B Tubulis buy for ADCsnews2026-04-07T12:17:00+00:00April 7th, 2026|Endpoints News|
BioNTech to shutter Singapore HQ after ‘comprehensive review’news2026-04-07T11:20:12+00:00April 7th, 2026|Endpoints News|
Proposed FDA budget sets Makary up to boost US biotechnews2026-04-06T18:38:19+00:00April 6th, 2026|Endpoints News|
Neurocrine will pay $2.9B for Soleno and its Prader-Willi medicinenews2026-04-06T11:32:55+00:00April 6th, 2026|Endpoints News|
Trump signs order to put 100% pharma tariffs on drugs, countries without trade dealsnews2026-04-02T19:59:29+00:00April 2nd, 2026|Endpoints News|
DOJ weighs in favor of pharma on 340B disputenews2026-04-02T17:49:02+00:00April 2nd, 2026|Endpoints News|
Trump is preparing 100% tariffs on some drugmakers, documents shownews2026-04-02T14:04:53+00:00April 2nd, 2026|Endpoints News|
